• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prometheus Biosciences, Inc. - Common Stock (NQ:RXDX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 15, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 199.92 (9)
Ask (Size) 199.99 (7)
Prev. Close 199.92
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 41,700,063
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Shares of Exscientia Jumped on Wednesday
July 12, 2023
The company may be riding the wave of an AI healthcare boom. 
Via The Motley Fool
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
July 07, 2023
Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as... 
Via Benzinga

Performance

More News

Read More
Why Shares of Ventyx Biosciences Rose Monday
July 03, 2023
Via The Motley Fool
Is Merck Stock a Top Buy Right Now?
June 19, 2023
Via The Motley Fool
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Via Investor's Business Daily
3 Innovative Growth Stocks to Buy for Next-Gen Profits
May 31, 2023
Via InvestorPlace
RXDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Prometheus Biosciences, Inc. Is Fair to Shareholders
May 24, 2023
From Halper Sadeh LLC
Via Business Wire
PROMETHEUS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX
May 22, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
3 Undervalued Pharma Stocks to Buy for High Total Returns
May 19, 2023
Via InvestorPlace
FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
May 16, 2023
Via Benzinga
Horizon Tumbles — Taking Seagen, Prometheus With It — On Reports FTC Could Block Its Amgen Takeover
May 16, 2023
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
May 10, 2023
Via Benzinga
Prometheus Biosciences Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Progress
May 09, 2023
From Prometheus Biosciences
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth’s Inc. (Nasdaq – RUTH), Magenta Therapeutics, Inc. (Nasdaq – MGTA), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX)
May 03, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)
May 01, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
Here Are The Best-Performing Industry ETFs And Major Stock Contributors In April
April 30, 2023
Via Benzinga
Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?
April 28, 2023
Via Investor's Business Daily
Merck Makes a Bold Move That Could Transform Its Business
April 27, 2023
Via The Motley Fool
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
Via The Motley Fool
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE – UNVR)
April 25, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
This Supercharged Dividend King Stock Might Soon Run Out of Steam
April 25, 2023
Via The Motley Fool
PROMETHEUS BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Prometheus Biosciences, Inc. - RXDX
April 21, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review
April 21, 2023
Via Investor's Business Daily
Why Prometheus Biosciences Stock Is Skyrocketing This Week
April 20, 2023
Via The Motley Fool
Why This Nasdaq Stock Caught Fire This Week
April 20, 2023
Via The Motley Fool

Frequently Asked Questions

Is Prometheus Biosciences, Inc. - Common Stock publicly traded?
Yes, Prometheus Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Prometheus Biosciences, Inc. - Common Stock trade on?
Prometheus Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Prometheus Biosciences, Inc. - Common Stock?
The ticker symbol for Prometheus Biosciences, Inc. - Common Stock is RXDX on the Nasdaq Stock Market
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap